PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-10-04

Date Title Company
04-Oct-2022 Freeline Initiates Dosing of Second Cohort in MARVEL-1 Trial of FLT190 Gene Therapy Candidate for People with Fabry Disease Freeline Therapeutics
04-Oct-2022 Immutep Receives FDA Fast Track Designation for LAG-3 Therapeutic Eftilagimod Alpha for First Line Non-Small Cell Lung Cancer Immutep
04-Oct-2022 Personalis Forms Research Collaboration to Better Predict Immunotherapy Response for Gastroesophageal Cancer Businesswire
04-Oct-2022 Oligomerix Awarded $2.49M from NIH to Further Support Clinical Development of Tau-Targeting Alzheimer’s Disease Therapy Candidate OLX-07010 Businesswire
04-Oct-2022 RAIN Alliance Names New President and CEO Businesswire
04-Oct-2022 A Transformational Year: ImaginAb expands Pipeline to include Radiopharmaceutical Therapies, enters Multiple Partnerships, and Drives Forward Development of Investigational CD8 ImmunoPET Agent ImaginAb
04-Oct-2022 Cellusion and Minaris Regenerative Medicine, a Member of Showa Denko Materials, Enter into Business Alliance for the Manufacturing of CLS001 for a Corneal Endothelial Cell Regenerative Therapy Cellusion
04-Oct-2022 Heidelberg Pharma AG Announces Adjustment of Guidance Heidelberg Pharma AG
04-Oct-2022 Biolog-id Launches an Innovative High-Density (HD) RFID Kit Targeting the High-Volume Needs of Blood Centers and Large Hospital Blood Banks Biolog-id
04-Oct-2022 Shionogi and the Medicines Patent Pool (MPP) sign licence agreement for COVID-19 oral antiviral treatment candidate to increase access in low- and middle-income countries Shionogi
04-Oct-2022 InnoScot Health focusses in on ophthalmic innovation with new call InnoScot Health
04-Oct-2022 Thermo Fisher Scientific Adds New Ultra-Low Temperature Chest Freezer to Green Portfolio, Offering Eco-Friendly, Compliant, and Secure Cold Storage Businesswire
04-Oct-2022 Adaptive Phage Therapeutics Awarded Additional $5 Million from U.S. Defense Health Agency to Support Diabetic Foot Osteomyelitis Clinical Trial Businesswire
04-Oct-2022 Global Precision and Personalized Medicine Thematic Research Report 2022 - ResearchAndMarkets.com Businesswire
04-Oct-2022 Evolus Broadens Its International Presence with Nuceiva® Launch in Great Britain Businesswire
04-Oct-2022 Global Aspirin Market Report 2022: Growing Demand for Branded Generics to Boost Sector - ResearchAndMarkets.com Businesswire
04-Oct-2022 Middle East Respiratory Syndrome (MERS) Drug Pipeline Market Insights Report 2022: 12+ Companies and 12+ Pipeline Drugs in the Pipeline Landscape - ResearchAndMarkets.com Businesswire
04-Oct-2022 Cyclo Therapeutics Commences Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer’s Disease Businesswire
04-Oct-2022 Frazier Life Sciences Adds Experienced Biopharmaceutical Executive to Team Businesswire
04-Oct-2022 Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 26, 2022 Businesswire